Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 May 23;12(6):672.
doi: 10.3390/children12060672.

Sarcoidosis-like Skin Lesions as the First Manifestation of Ataxia-Telangiectasia

Affiliations
Case Reports

Sarcoidosis-like Skin Lesions as the First Manifestation of Ataxia-Telangiectasia

Borko Milanovic et al. Children (Basel). .

Abstract

Ataxia-telangiectasia is a rare autosomal recessive disorder that is difficult to diagnose due to its unpredictable presentation. It is characterized by cerebellar degeneration, telangiectasias, immunodeficiency, frequent pulmonary infections, and tumors. Immune system abnormalities manifest as disruptions in both cellular and humoral immunity. The most common findings include decreased levels of immunoglobulin classes (IgA, IgM, IgG, and IgG subclasses) and a reduced number of T and B lymphocytes. A four-year-old girl was initially evaluated and treated for skin lesions that presented as crusts spreading across her body. She was monitored by a pulmonologist due to frequent bronchial obstructions. Over time, she developed bilateral scleral telangiectasia, saccadic eye movements, and impaired convergence. Her gait was wide-based and unstable, with truncal ataxia and a positive Romberg sign. Laboratory tests revealed decreased immunoglobulin G levels, subclass IgG4 levels, elevated alpha-fetoprotein, and a reduced number of T and B lymphocytes. Brain magnetic resonance imaging showed cerebellar atrophy. Whole-exome sequencing identified heterozygous variants c.1564-165del, p.(Glu5221lefsTer43), and c.7630-2A>C in the serine/threonine-protein kinase ATM (ataxia-telangiectasia mutated) gene, confirming the diagnosis of ataxia-telangiectasia. Following diagnosis, treatment with intravenous immunoglobulin replacement was initiated along with infection prevention and management. The goal of this case report is to raise awareness of the atypical initial presentation that may lead to a diagnostic delay. We emphasize the importance of considering ataxia-telangiectasia in the differential diagnosis, even when classical neurological signs are not yet evident.

Keywords: ataxia-telangiectasia; cerebellar degeneration; chronic granulomatous skin disease; immunodeficiency.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Cutaneous granulomatous lesions on the lateral and posterior part of the upper left arm (A) and on the anterior part of the right thigh (B) clinically mimicking sarcoid-like dermatoses. The lesions presented as erythematous to livid firm nodules with central desquamation. Images were taken on the same day during the same stage of the disease.
Figure 2
Figure 2
Chronic granulomatous dermatitis and lobular panniculitis. (A) Microphotography of skin biopsy with granulomatous inflammation in dermis and in subcutaneous adipose tissue (HE × 50). (B) Detail of granuloma with giant cell (HE × 200). the arrow represents a granuloma with giant cell. (C) Granulomatous panniculitis (HE × 200).
Figure 3
Figure 3
T2-weighted MRI sequences of the brain demonstrate bilateral cerebellar hemispheric and vermis atrophy (B1,B2) in comparison to prior imaging performed three years before, when these structures appeared normal (A1,A2). The red arrow represents cerebellar athrophy.

Similar articles

References

    1. Alyasin S., Esmaeilzadeh H., Ebrahimi N., Nabavizadeh S.H., Nemati H. Clinical presentation of ataxia-telangiectasia. Arch. Iran. Med. 2019;22:682–686. - PubMed
    1. Anheim M., Tranchant C., Koenig M. The autosomal recessive cerebellar ataxias. N. Engl. J. Med. 2012;366:636–646. doi: 10.1056/NEJMra1006610. - DOI - PubMed
    1. Rothblum-Oviatt C., Wright J., Lefton-Greif M.A., McGrath-Morrow S.A., Crawford T.O., Lederman H.M. Ataxia telangiectasia: A review. Orphanet J. Rare Dis. 2016;11:159. doi: 10.1186/s13023-016-0543-7. - DOI - PMC - PubMed
    1. Van Os N.J., Jansen A.F.M., van Deuren M., Haraldsson A., van Driel N.T.M., Etzioni A., van der Flier M., Haaxma C.A., Morio T., Rawat A., et al. Ataxia-telangiectasia: Immunodeficiency and survival. Clin. Immunol. 2017;178:45–55. doi: 10.1016/j.clim.2017.01.009. - DOI - PubMed
    1. Takada S., Weitering T.J., van Os N.J., Du L., Pico-Knijnenburg I., Kuipers T.B., Mei H., Salzer E., Willemsen M.A., Weemaes C.M., et al. Causative mechanisms and clinical impact of immunoglobulin deficiencies in ataxia telangiectasia. J. Allergy Clin. Immunol. 2024;153:1392–1405. doi: 10.1016/j.jaci.2023.12.029. - DOI - PubMed

Publication types

LinkOut - more resources